Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Ovid Therapeutics (OVID) had Debt to Capital Ratio of 0.06 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-16.99M |
|
-- |
|
-- |
|
$17.85M |
|
$-17.85M |
|
$0.86M |
|
$-16.99M |
|
$-16.99M |
|
$-16.99M |
|
$-16.99M |
|
$-16.99M |
|
$-16.99M |
|
$-17.85M |
|
$-17.81M |
|
136.17M |
|
136.17M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$160.15M |
|
$0.22M |
|
$65.48M |
|
$225.63M |
|
$15.75M |
|
$11.61M |
|
$11.61M |
|
$27.36M |
|
$198.27M |
|
$198.27M |
|
$198.27M |
|
167.27M |
|
| Cash Flow Statement Financials | |
$-13.90M |
|
$5.95M |
|
$88.98M |
|
$15.08M |
|
$96.00M |
|
$80.91M |
|
$1.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.17 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.06 |
0.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.90M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.57% |
|
-8.57% |
|
-7.53% |
|
-8.09% |
|
$1.19 |
|
$-0.10 |
|
$-0.10 |
|